Lyme neuroborreliosis diagnosis had no substantial effect on long-term survival, health, or educational/social functioning yet may be associated with an increased risk of hematologic and nonmelanoma skin cancers.
During 2004 to 2016, 82% of all tickborne disease reports were Lyme disease
The first set of blood screening tests for the tickborne parasite Babesia microti have been approved by the US Food and Drug Administration.
A 52-year-old man presents to the emergency department with dizziness and fatigue after a syncopal episode on a camping trip.
Clinician suspicion has minimal accuracy for the diagnosis of Lyme disease.
Clinicians and patients should be aware that treatments for chronic Lyme disease can carry serious risks.
Individuals have a higher risk of tick bites and tickborne diseases from May through July.
The Lyme disease spirochete, Borrelia burgdorferi, is an obligate parasite and the most common tick-borne infection in North America and Europe.
The number of counties in the United States with a high risk for Lyme disease is rising.
Educating patients about Lyme disease can help avoid unnecessary appointments and testing.
Some patients who are experiencing flulike symptoms might actually be afflicted with babesiosis, a malaria-like disease that peaks from May to September.